Responding to customer needs with ergonomic design
Redesigned Thermo Scientific Finnpipette F1 and F1-ClipTip pipettes now have added features designed to improve user comfort and productivity (Photo: Business Wire)
Enhancements to Thermo Scientific Finnpipette F1 and F1-ClipTip pipetting systems improve comfort.
Two pipetting systems designed for accurate liquid transfer in a range of applications spanning high-throughput pharmaceutical and biotechnology laboratories to small academic and industrial laboratories are now redesigned for enhanced comfort.
For decades, Thermo Scientific Finnpipette pipetting systems have been designed for exceptional productivity and ergonomic utility across thousands of laboratories and applications worldwide. The redesigned Finnpipette F1 pipettes and Thermo Scientific F1-ClipTip pipettes now have added features designed to improve user comfort and productivity:
“Effective liquid handling is critical to ensuring experimental accuracy and as such, users need dispensing tools that can repeatedly and reliably deliver accurate volumes,” said Kelly Miller, business director of liquid handling consumables, at Thermo Fisher Scientific. “When designing upgrades for our ClipTip and Finnpipette systems, we spent time talking to our existing customers to identify their common pain points and set out to enhance their user experience. One result of the new lightweight design is that it supports the reduction of hand fatigue, and the lower pipetting forces will decrease the risk of RSI during extended use.”
These two pipetting systems are uniquely designed for different application needs. F1-ClipTip pipettes feature an interlocking tip attachment that ensures a complete seal on every channel with minimal attachment and ejection force. Once attached, the tips are locked firmly in place and are designed not to loosen or fall off, regardless of application pressure. The F1-ClipTip pipettes are designed for medium-to-high-throughput laboratories that are concerned with ergonomics, sample security, speed and improved accuracy. The Finnpipette F1 pipettes deliver the same ergonomic benefit in a lightweight design that maximizes user comfort and reduces strain. The Super Blow-out technology for effective delivery of microvolumes makes the Finnpipette F1 an ideal system for applications that use expensive reagents and valuable samples.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.